These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39154161)

  • 1. The role and mechanism of thrombospondin-4 in pulmonary arterial hypertension associated with congenital heart disease.
    Zeng H; Lan B; Li B; Xie H; Zhao E; Liu X; Xue X; Sun J; Su L; Zhang Y
    Respir Res; 2024 Aug; 25(1):313. PubMed ID: 39154161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
    Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
    J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertension.
    Zhou JJ; Li H; Li L; Li Y; Wang PH; Meng XM; He JG
    J Cell Physiol; 2021 Sep; 236(9):6297-6311. PubMed ID: 33507567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt-related pulmonary arterial hypertension.
    Zhou JJ; Yang J; Li L; Quan RL; Chen XX; Qian YL; Huang L; Wang PH; Li Y; Meng XM; Chen X; Gu Q; He JG
    ESC Heart Fail; 2022 Oct; 9(5):3407-3417. PubMed ID: 35841124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. eIF2α promotes vascular remodeling via autophagy in monocrotaline-induced pulmonary arterial hypertension rats.
    Guo L; Li Y; Tian Y; Gong S; Chen X; Peng T; Wang A; Jiang Z
    Drug Des Devel Ther; 2019; 13():2799-2809. PubMed ID: 31496656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
    Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
    Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synemin promotes pulmonary artery smooth muscle cell phenotypic switch in shunt-induced pulmonary arterial hypertension.
    Zhou J
    ESC Heart Fail; 2022 Oct; 9(5):3221-3231. PubMed ID: 35769011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension.
    Chen X; Yu X; Lian G; Tang H; Yan Y; Gao G; Huang B; Luo L; Xie L
    Biomed Pharmacother; 2024 May; 174():116505. PubMed ID: 38574614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
    He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
    Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells.
    Gao L; Fan Y; Hao Y; Yuan P; Liu D; Jing Z; Zhang Z
    Int J Med Sci; 2017; 14(9):820-828. PubMed ID: 28824319
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling.
    Zhang S; Wang J; Qi X; Tao X; Xie W; Wan J; Shen YH; Zhai Z
    Exp Cell Res; 2021 Jan; 398(1):112392. PubMed ID: 33227315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The zinc transporter ZIP12 regulates monocrotaline-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/ERK signaling pathways.
    Ye C; Lian G; Wang T; Chen A; Chen W; Gong J; Luo L; Wang H; Xie L
    BMC Pulm Med; 2022 Mar; 22(1):111. PubMed ID: 35346134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel roles of YULINK in the migration, proliferation and glycolysis of pulmonary arterial smooth muscle cells: implications for pulmonary arterial hypertension.
    Wu YC; Wang WT; Yang MC; Su YT; Yeh JL; Hsu JH; Wu JR
    Biol Res; 2023 Dec; 56(1):66. PubMed ID: 38057829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension.
    Yamamura A; Fujiwara M; Kawade A; Amano T; Hossain A; Nayeem MJ; Kondo R; Suzuki Y; Inoue Y; Hayashi H; Suzuki S; Sato M; Yamamura H
    Eur J Pharmacol; 2024 Jun; 973():176564. PubMed ID: 38614383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
    Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
    Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of eIF2α by m
    Zhang J; Huang WQ; Zhang YR; Liang N; Li NP; Tan GK; Gong SX; Wang AP
    J Cardiovasc Transl Res; 2024 Jun; 17(3):598-608. PubMed ID: 37973667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing EIF3A ameliorates pulmonary arterial hypertension through HDAC1 and PTEN/PI3K/AKT pathway in vitro and in vivo.
    Yang HT; Wang G; Zhu PC; Xiao ZY
    Exp Cell Res; 2023 May; 426(1):113555. PubMed ID: 36921705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DAN plays important compensatory roles in systemic-to-pulmonary shunt associated pulmonary arterial hypertension.
    Meng L; Liu X; Teng X; Yuan W; Duan L; Meng J; Li J; Zheng Z; Wei Y; Hu S
    Acta Physiol (Oxf); 2019 Jul; 226(3):e13263. PubMed ID: 30715799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone Contributed to Pulmonary Arterial Hypertension Development via Stimulating Aquaporin Expression and Pulmonary Arterial Smooth Muscle Cells Proliferation.
    Wang Y; Zhong B; Wu Q; Zhu T; Wang Y; Zhang M
    Pharmacology; 2020; 105(7-8):405-415. PubMed ID: 31995798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.